IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 19 filers reported holding IBERE PHARMACEUTICALS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hartree Partners, LP | 1,285,000 | $12,875,700,000 | 3.00% |
| Wealthspring Capital LLC | 231,182 | $2,317,000 | 0.50% |
| KRYGER CAPITAL Ltd | 385,240 | $3,860,000 | 0.22% |
| Schechter Investment Advisors, LLC | 210,692 | $2,111,000 | 0.19% |
| Sage Mountain Advisors LLC | 89,180 | $894,000 | 0.11% |
| Context Capital Management, LLC | 115,053 | $1,153,000 | 0.09% |
| Magnetar Financial LLC | 784,909 | $7,865,000 | 0.08% |
| ARISTEIA CAPITAL, L.L.C. | 350,000 | $3,507,000 | 0.06% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 36,569 | $366,000 | 0.05% |
| Bulldog Investors, LLP | 15,000 | $150,000 | 0.04% |